Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis. - Wikidata - wikimedia - TriplyDB

Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.

Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.

http://www.wikidata.org/entity/Q34267584

about

Genome-wide modulation of gene transcription in ovarian carcinoma cells by a new mithramycin analogue NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.Damaged DNA-binding protein 2 (DDB2) protects against UV irradiation in human cells and Drosophila.DDB2 suppresses tumorigenicity by limiting the cancer stem cell population in ovarian cancer.Damaged DNA-binding protein down-regulates epigenetic mark H3K56Ac through histone deacetylase 1 and 2.Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells Combination of Aβ Secretion and Oxidative Stress in an Alzheimer-Like Cell Line Leads to the Over-Expression of the Nucleotide Excision Repair Proteins DDB2 and XPC DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.Damaged DNA binding protein 2 in reactive oxygen species (ROS) regulation and premature senescence Nucleotide excision repair deficiency in melanoma in response to UVA.Differential DNA lesion formation and repair in heterochromatin and euchromatin DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.Stem cell protein Piwil2 modulates chromatin modifications upon cisplatin treatment.A DDB2 mutant protein unable to interact with PCNA promotes cell cycle progression of human transformed embryonic kidney cells.Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer.Cdt2-mediated XPG degradation promotes gap-filling DNA synthesis in nucleotide excision repair.Damaged-DNA Binding Protein-2 Drives Apoptosis Following DNA Damage.DDB2 association with PCNA is required for its degradation after UV-induced DNA damage.Human CRL4DDB2 ubiquitin ligase preferentially regulates post-repair chromatin restoration of H3K56Ac through recruitment of histone chaperon CAF-1.DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.

P2860

Q28541775-2F9EEB83-B824-4BA1-9FB2-6ECDC562EA1B Q33591581-B0812A0C-C5A6-40A0-809E-F18E24055098 Q33828372-0369E76E-0F48-49BD-A308-894EB1050C04 Q33894314-257C48B3-C85E-4F41-824A-0544BE14B4EB Q34488874-FC298F18-FF6B-49EB-9C74-F3438CC1C3DA Q34722650-83BB7A97-4EBE-4FED-B100-0380C57CC292 Q36088466-9304D72B-63F0-4950-A782-80F1339B35AC Q36299135-F068ED98-70EA-4784-8998-5BEB3850451A Q36321751-FC00A062-02CE-4E80-8929-9EFF3C7CE814 Q36612048-52E0BE2A-5D95-41F6-9954-C84E9AB802CF Q37220505-C31A61C8-79B0-4AE7-A93E-675ADF9C0BD3 Q37656349-366EE655-0D2B-47E6-BE3F-148962D3AD25 Q39594601-9D858F22-E2A7-4D05-91EE-1DDCB75D6B52 Q39987578-0300DCEE-1209-418B-8FBE-C01DCDF75F81 Q41718006-996F71A6-E38E-4116-ACD1-35FE255CDFEE Q41719581-9B1CCD29-672B-478C-834F-4743CF2F5437 Q41834968-E7167F92-E35E-4047-8EBC-0E518291022A Q41899022-2EF45797-22BC-47BA-9FFD-4714631C9FCF Q47217424-A3800513-7122-4C83-B1FC-C8972576CA11 Q55048537-A9D8C3B1-9AAF-4D42-AD9F-EADBF3609B1C

P2860

Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.

http://www.wikidata.org/entity/Q34267584

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Overexpression of DDB2 enhance ...... augmenting cellular apoptosis.

@ast

Overexpression of DDB2 enhance ...... augmenting cellular apoptosis.

@en

Overexpression of DDB2 enhance ...... augmenting cellular apoptosis.

@nl

type

label

Overexpression of DDB2 enhance ...... augmenting cellular apoptosis.

@ast

Overexpression of DDB2 enhance ...... augmenting cellular apoptosis.

@en

Overexpression of DDB2 enhance ...... augmenting cellular apoptosis.

@nl

prefLabel

Overexpression of DDB2 enhance ...... augmenting cellular apoptosis.

@ast

Overexpression of DDB2 enhance ...... augmenting cellular apoptosis.

@en

Overexpression of DDB2 enhance ...... augmenting cellular apoptosis.

@nl

P1433

Q34267584-CE8BE794-7E1F-4A6B-ACBD-E987C8FB5040

P1476

Q34267584-18777947-EE3B-4CBE-9892-8A900E3E1165

P2093

Q34267584-245D2A9D-AB17-4F10-B438-CBF5DB4948EF

Q34267584-3211AECD-1177-438F-A7F1-565F4DBE3D2D

Q34267584-444DD4FE-C20B-444B-9751-E21B73D4312E

Q34267584-52038100-3788-4BA8-84C1-4A8106C490A8

Q34267584-876B7ADA-67B7-4E58-9294-6AEC313ED15D

Q34267584-B661D992-35C6-4D54-A436-07F6FBC3E9EE

Q34267584-E0B0ED2C-13F2-4154-9D31-A14ACE4B56E0

Q34267584-E2B303E2-EE8C-49BA-A1DF-A66F95C5F5EC

Q34267584-E7C9268A-879A-4DC1-8457-8DFD5D17E4EB

Q34267584-F05085C3-948A-44BD-AAA3-D7D7BC6DADA4

P2860

Q34267584-0698CB83-B46C-4826-9AF6-1112B27F9314

Q34267584-0C17E35A-5719-4619-BEEA-17BF9DE9CEC5

Q34267584-12C850A5-1F29-4083-83F9-B0382704E863

Q34267584-1B32595B-5671-49A8-A57F-369772E93929

Q34267584-1B792245-F156-4521-9B00-555931CF0458

Q34267584-1D27660B-3FF5-43EB-A67A-E706BECFBE9A

Q34267584-1FC6E0D6-41D7-4B4C-B1EC-A40DBFA5156C

Q34267584-26C25CF1-E169-4707-BFFF-203F075E1FB4

Q34267584-2A06E3CD-8306-463F-B1FA-DDA01A6797EE

Q34267584-30633AA5-5D5A-48C2-8FB8-72F0A978FAFC

P304

Q34267584-0D50C682-DB68-4C95-A017-101778791C55

P31

Q34267584-03813921-4CA8-4FE3-9B07-05DA1389C762

P356

Q34267584-75A7A5F2-DC0E-490D-A147-08E1035708C8

P433

Q34267584-F7FB9E90-0E63-4F74-91FA-21311C54E210

P478

Q34267584-685D99AD-48CC-4901-B2B2-73E6725C844B

P577

Q34267584-2698E3E1-0947-4330-BC54-1CF59F60C46A

P5875

Q34267584-5B367BAF-A58C-416B-BD9A-FD1A84712030

P698

Q34267584-FDF9995A-183F-4219-A511-E1BAF7AA4804

P921

Q34267584-90CE8BE0-3E49-489A-A0D2-35A9CA0F5A17

Q34267584-A09DC9AC-2C93-4839-ABCE-D97C5FD5F610

P932

Q34267584-EBA13146-1082-4341-9B6A-48ED2E65E6D7

P356

P1433

International Journal of Cancer

P1476

Overexpression of DDB2 enhance ...... augmenting cellular apoptosis.

@en

P2093

Altaf A Wani

http://www.w3.org/2001/XMLSchema#string

Bassant M Barakat

http://www.w3.org/2001/XMLSchema#string

Chunhua Han

http://www.w3.org/2001/XMLSchema#string

De-Tao Yin

http://www.w3.org/2001/XMLSchema#string

El-Shaimaa A Arafa

http://www.w3.org/2001/XMLSchema#string

Gulzar Wani

http://www.w3.org/2001/XMLSchema#string

Keisha Milum

http://www.w3.org/2001/XMLSchema#string

Mohamed A El-Mahdy

http://www.w3.org/2001/XMLSchema#string

Qi-En Wang

http://www.w3.org/2001/XMLSchema#string

Qun Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

DDB, a putative DNA repair protein, can function as a transcriptional partner of E2F1.

Sequential binding of UV DNA damage binding factor and degradation of the p48 subunit as early events after UV irradiation.

DNA repair factor XPC is modified by SUMO-1 and ubiquitin following UV irradiation

NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin

Solution-state structure of a DNA dodecamer duplex containing a Cis-syn thymine cyclobutane dimer, the major UV photoproduct of DNA

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

Chromosomal localization and cDNA cloning of the genes (DDB1 and DDB2) for the p127 and p48 subunits of a human damage-specific DNA binding protein

Cisplatin: mode of cytotoxic action and molecular basis of resistance

P304

977-988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.25112

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40691187

http://www.w3.org/2001/XMLSchema#string

P698

20013802

http://www.w3.org/2001/XMLSchema#string

P921

P932

4180185

http://www.w3.org/2001/XMLSchema#string